ALTACE Tablets (ramipril) WARNING: FETAL TOXICITY

Altace Tablets (ramipril) USE IN PREGNANCY When used in pregnancy during the second and third trimesters, ACE inhibitors

Altace Tablets (ramipril) are supplied as tablets for oral administration containing 1.25 mg, 2.5 mg, 5 mg and 10 mg of ramipril. The inactive ingredients present are calcium sulphate dihydrate, pregelatinized starch, sodium bicarbonate, and sodium stearyl fumarate. The 2.5 mg tablet contains yellow iron oxide and FD&C yellow #6, the 5 mg tablet contains FD&C yellow #6 and FD&C red #40, and the...

ATACAND HCT 16-12.5 (candesartan cilexetil−hydrochlorothiazide) TABLETS, FOR ORAL USE ATACAND HCT 32-12.5 (candesartan cilexetil−hydrochlorothiazide) TABLETS, FOR ORAL USE ATACAND HCT 32–25 (candesartan cilexetil-hydrochlorothiazide) TABLETS, FOR ORAL USE WARNING: FETAL TOXICITY

ZESTRIL (lisinopril) Tablets WARNING: FETAL TOXICITY

Lisinopril is a white to off-white, crystalline powder, with a molecular weight of 441.53. It is soluble in water and sparingly soluble in methanol and practically insoluble in ethanol. ZESTRIL is supplied as 2.5 mg, 5 mg, 10 mg, 20 mg, 30 mg and 40 mg tablets for oral administration. Inactive Ingredients: 2.5 mg tablets calcium phosphate, magnesium stearate, mannitol, starch. 5, 10, 20 and 30 ...

Zestril (lisinopril) tablets, for oral use lABEL

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ZESTRIL safely and effectively. See full prescribing information for ZESTRIL Zestril (lisinopril) tablets, for oral use Initial U.S. Approval: 1988 WARNING: FETAL TOXICITY See full prescribing information for complete boxed warning.  When pregnancy is detected, discontinue Zestril as soon as...

These highlights do not include all the information needed to use LOSARTAN POTASSIUM TABLETS safely and effectively. See full prescribing information for LOSARTAN POTASSIUM TABLETS. LOSARTAN POTASSIUM tablets, for oral useRx Only Initial U.S. Approval: 1995

FULL PRESCRIBING INFORMATION: CONTENTS* WARNING: FETAL TOXICITY 1 INDICATIONS AND USAGE 1.1 Hypertension 1.2 Hypertensive Patients with Left Ventricular Hypertrophy 1.3 Nephropathy in Type 2 Diabetic Patients 2 DOSAGE AND ADMINISTRATION 2.1 Hypertension 2.2 Hypertensive Patients with Left Ventricular Hypertrophy 2.3 Nephropathy in Type 2 Diabetic Patients 2.4 Dosage Modifications in Patients wi...